Spectrum Pharmaceuticals (NASDAQ:SPPI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 25 percent increase over losses of $(0.16) per share from the same period last year.
Spectrum Pharmaceuticals Q3 EPS $(0.12) Beats $(0.15) Estimate
Spectrum Pharmaceuticals (NASDAQ:SPPI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 25 percent increase over losses of $(0.16) per share
Related Posts
Truist Securities Maintains Hold on Cracker Barrel Old, Lowers Price Target to $101
December 5, 10:34 AM
Truist Securities analyst Jake Bartlett maintains Cracker Barrel Old (NASDAQ:CBRL) with a Hold and lowers the price target from $109 to $101.
A Preview Of Chesapeake Energy’s Earnings
October 31, 3:25 PM
Chesapeake Energy (NASDAQ:CHK) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement.
Analysts estimate that Chesapeake Energy will report an earnings per share (EPS) of $4.48.
Jim Cramer: ‘Nothing Terrific’ About GitLab, But Rocket? Time To ‘Ka-Ching, Ka-Ching’
April 5, 8:55 AM
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he didn’t like the last quarter of GitLab Inc. (NASDAQ: GTLB). "I went over it with a fine tooth comb.